The CatSci team are looking forward to exhibiting at ChemOutsourcing (COS) New Jersey, taking place on 6th – 8th September 2023 in Parsippany, NJ. You can find us at Booth 61.
Attending COS will be:
- Dr Simon Tyler, Chief Commercial Officer
- Dr Jas Douville, Head of Business Development – North America
- Dr Jenny Wallis, Head of Business Development – New England
- Autumn Collins, Business Development Manager
Simon, Jas, Jenny & Autumn are looking forward to networking with the industry and discussing how CatSci can address your dynamic portfolio demands with perfect-for-purpose solutions tailored to your needs.
At CatSci, we know it is no easy feat to advance your assets into clinic and through development. Our end-to-end integrated capabilities include chemical development, crystallisation and solid state, preformulation, HPAPI development, and oligonucleotides. Our offerings, along with our decades of expertise and commitment to scientific excellence, enable you to accelerate your medicines development programmes.
Plus, our partnership with AGC Pharma Chemicals, a global CDMO, allows us to provide scalable small molecule API manufacturing, from grams to tonnes, meeting the requisite quality, timelines and budget to support projects from pre-clinical development to large scale commercial production. This partnership eases your journey through the product development lifecycle and, even more importantly, expedites the delivery of life-changing new medicines to patients worldwide.
If you’re interested in learning about how CatSci can accelerate your path to clinic, then speak to us at COS. Arrange a meeting with us to find out how you can leverage our integrated programmes to overcome your pipeline challenges. We look forward to seeing you there.
